Kv Cited by FDA for False Data Firm Also May Lose Right to Sell Two Heart Drugs

By Robert Steyer Of the Post-Dispatch | St Louis Post-Dispatch (MO), December 11, 1994 | Go to article overview

Kv Cited by FDA for False Data Firm Also May Lose Right to Sell Two Heart Drugs


Robert Steyer Of the Post-Dispatch, St Louis Post-Dispatch (MO)


KV Pharmaceutical Co. of Brentwood is one of 19 companies on a special Food and Drug Administration warning list, government documents say.

The FDA, which regulates thousands of medical companies, only puts a firm on the warning list when it is

cited for extreme or repeated cases of providing "false and misleading" data.

"False and misleading information" for some product applications raised "significant questions with regard to the reliability" of KV's test data, says one document explaining why KV has been on the list since April 1993.

Until KV corrects the problems, the FDA has halted scientific review of some drugs submitted by KV for agency approval. The number of drugs is unknown.

KV, which makes timed-release drug technologies and generic drugs, has run afoul of the FDA before.

Twenty months ago, federal agents confiscated many of KV's prescription drugs following a raid on KV's headquarters, some plants and offices in the St. Louis area.

The FDA seized the drugs, charging that KV had failed to follow certain federal regulations covering "good manufacturing practices," including record-keeping and quality control.

Federal documents also say that the FDA is planning to revoke permission for KV to sell two types of prescription heart drugs.

The Post-Dispatch obtained the documents by making a request under the Freedom of Information Act. KV has never told shareholders that it is on the FDA list of companies making "false and misleading" statements.

Calls to KV's chief executive, vice chairman, corporate secretary, director of investor relations and assistant to the director of investor relations were not returned.

When a company seeks FDA approval of a product, it must submit test data showing that the drug is safe and effective. The company also must demonstrate that it can prove that its data is correct.

Companies that fail to meet this requirement can be placed on FDA's Applications Integrity Policy list, whose bureaucratic name doesn't adequately describe problems that FDA has investigated.

This list covers companies that have committed "fraud, untrue statements of material fact, bribery and/or illegal gratuities," the FDA says.

For a company to make the list, the FDA "must establish a pattern or practice of covered misconduct," Brad Williams, director of FDA's division of drug labeling compliance, said in a prepared statement.

"This has usually been falsification of original (product) applications, annual reports, supplements or bribery," he said.

If a company submits bad data, the FDA's response can be as strong as seizing products, ordering a recall or referring the matter to a federal grand jury.

KV landed on the FDA's list just before federal agents staged their raid on April 21, 1993.

"Your firm submitted false or misleading information in applications filed with this agency," says an April 14, 1993 letter to KV from Dr. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Kv Cited by FDA for False Data Firm Also May Lose Right to Sell Two Heart Drugs
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.